Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of ... Obesity and diabetes are the ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Turns out, you can’t outrun diabetes with a low BMI ... research shows that next-generation weight-loss drugs, like tirzepatide, could also reduce the risk of developing the disease in ...

specifically in reducing risk of cognitive decline. It is becoming clear that the benefits of these medications go beyond weight loss and diabetes control. And, of course, safety is important as ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered ... treated with a GLP-1 drug for diabetes had a lower risk of dementia. All of these studies ...

Weight-loss drugs such ... such as lowering the risk of stroke and dementia. Researchers used US Department of Veterans Affairs data to find people with diabetes who used drugs containing GLP ...

G LP-1 weight-loss drugs are as popular as ever. A Sept. 2024 poll found that roughly 12 percent of U.S. adults have used GLP ...

Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' of the disease. The injections were originally made to tackle diabetes ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...